Infectious Diseases I & II Flashcards

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering bacterial pathogens, antibiotic mechanisms, resistance patterns, and clinical treatment guidelines for infectious diseases.

Last updated 12:02 AM on 6/22/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

48 Terms

1
New cards

Gram-positive bacteria

Organisms characterized by a thick cell wall that stain dark purple or blue.

2
New cards

Gram-negative bacteria

Organisms characterized by a thin cell wall that stain pink.

3
New cards

Atypical bacteria

Organisms that have no cell wall and do not stain (e.g., Legionella, Mycoplasma, and Chlamydophila).

4
New cards

Presence of infection (criteria)

Clinical signs including fever (>100.4F> 100.4^{\circ}F), elevated WBC (>11,000cells/mm3> 11,000\,\text{cells/mm}^3), and site-specific symptoms like dysuria.

5
New cards

ESBL

Extended-spectrum beta-lactamase.

6
New cards

CRE

Carbapenem-resistant Enterobacterales.

7
New cards

VRE

Vancomycin-resistant Enterococcus.

8
New cards

Concentration-dependent killing

Dosing strategy where antibiotics like aminoglycosides are administered less frequently and in higher doses.

9
New cards

Time-dependent killing

Dosing strategy where antibiotics like beta-lactams are dosed more frequently or for longer durations (extended/continuous infusions) to stay above the MIC.

10
New cards

Bactericidal antibiotics

Antibiotics that kill bacteria, including cell wall inhibitors, cell membrane inhibitors, DNA/RNA inhibitors, and aminoglycosides.

11
New cards

Bacteriostatic antibiotics

Antibiotics that inhibit bacterial growth, including protein and folic acid synthesis inhibitors.

12
New cards

Hydrophilic antibiotics

Classes such as beta-lactams, vancomycin, and aminoglycosides that have small volumes of distribution, poor bioavailability, and are renally eliminated.

13
New cards

Lipophilic antibiotics

Classes such as quinolones, macrolides, and tetracyclines that have large volumes of distribution, excellent bioavailability (1:1 IV:PO), and hepatic elimination.

14
New cards

Penicillin G Benzathine (Bicillin L-A)

A natural penicillin administered IM only; IV administration can cause cardioresp arrest and death.

15
New cards

Antistaphylococcal Penicillins (e.g., Nafcillin, Oxacillin)

Antibiotics preferred for MSSA soft tissue, bone, joint, and bloodstream infections that do not require renal dose adjustments.

16
New cards

Aminopenicillins (e.g., Amoxicillin, Ampicillin)

Antibiotics covering Streptococci, Enterococci, and HNPEK; Amoxicillin is first-line for acute otitis media (90mg/kg/day90\,mg/kg/day).

17
New cards

Piperacillin/Tazobactam (Zosyn)

The only penicillin with Pseudomonas coverage; typically administered via extended 4-hour infusions.

18
New cards

1st Generation Cephalosporins (e.g., Cephalexin, Cefazolin)

Cephalosporins covering Gram-positive cocci (Strep, MSSA) and PEK; Cefazolin is used for surgical prophylaxis.

19
New cards

2nd Generation Cephalosporins (e.g., Cefotetan, Cefoxitin)

Cephalosporins with added anaerobic coverage (B. fragilis) often used for GI surgery prophylaxis; Cefotetan can cause disulfiram-like reactions.

20
New cards

3rd Generation Cephalosporins (e.g., Ceftriaxone, Ceftazidime)

Ceftriaxone is used for meningitis and CAP; Ceftazidime (Fortaz) has Pseudomonas activity but no Gram-positive activity.

21
New cards

4th Generation Cephalosporin (Cefepime)

A broad-spectrum antibiotic covering HNPEK, CAPES, Pseudomonas, and Gram-positives.

22
New cards

5th Generation Cephalosporin (Ceftaroline fosamil)

The only cephalosporin with activity against MRSA.

23
New cards

Ceftriaxone Contraindications

Should not be used in hyperbilirubinemic neonates or with Calcium-containing IV fluids in neonates < 28 days due to risk of biliary sludging.

24
New cards

Ertapenem (Invanz)

A carbapenem that lacks coverage against Pseudomonas, Acinetobacter, or Enterococcus (PEA).

25
New cards

Aztreonam (Azactam)

A monobactam with Gram-negative coverage only (including Pseudomonas) that has no cross-reactivity with penicillin allergies.

26
New cards

Aminoglycosides (Side Effects)

Major boxed warnings include nephrotoxicity, ototoxicity, and neuromuscular blockade; requires monitoring of peak and trough levels.

27
New cards

Gentamicin/Tobramycin Traditional Dosing

12.5mg/kg/dose1-2.5\,mg/kg/dose with a goal trough of <2μg/mL< 2\,\mu g/mL (<1μg/mL< 1\,\mu g/mL for synergy).

28
New cards

Quinolones (Mechanism of Action)

Antibiotics that inhibit bacterial DNA topoisomerase IV and DNA gyrase.

29
New cards

Quinolone Black Box Warnings

Tendon inflammation and rupture, peripheral neuropathy, and CNS effects (seizures, tremor, suicidality).

30
New cards

Respiratory Quinolones

Levofloxacin and Moxifloxacin; specifically used for S. pneumoniae and atypicals in CAP.

31
New cards

Moxifloxacin (Avelox)

The only quinolone that cannot be used to treat UTIs.

32
New cards

Macrolides (e.g., Azithromycin, Clarithromycin)

Antibiotics with excellent atypical coverage (Legionella, Mycoplasma, Chlamydia); warnings include QT prolongation and hepatotoxicity.

33
New cards

Tetracyclines (Contraindications)

Avoid in children < 8 years old, pregnancy, and breastfeeding due to tooth discoloration and skeletal development suppression.

34
New cards

SMX/TMP (Bactrim) Warnings

Sulfa allergy, SJS/TEN, thrombotic purpura, and hyperkalemia; compatible with D5W only.

35
New cards

Vancomycin (Vancocin)

First-line IV treatment for MRSA; requires AUC/MIC ratio monitoring (goal 400-600) and can cause infusion reactions ('Red Man Syndrome').

36
New cards

Daptomycin (Cubicin)

A cyclic lipopeptide used for MRSA and VRE; should NOT be used for pneumonia as it is inactivated by lung surfactant.

37
New cards

Linezolid (Zyvox)

An oxazolidinone covering MRSA and VRE; warnings include myelosuppression (thrombocytopenia), serotonin syndrome, and optic neuropathy.

38
New cards

Quinupristin/Dalfopristin (Synercid)

A medication used for VRE (E. faecium) that is poorly tolerated and requires a central line to prevent phlebitis.

39
New cards

Tigecycline (Tygacil)

A broad-spectrum antibiotic with a BBW for increased risk of death; has no activity against the '3 Ps' (Pseudomonas, Proteus, Providencia).

40
New cards

Clindamycin (Cleocin)

A lincosamide with a BBW for C. diff colitis; requires an induction test (D-test) if S. aureus is resistant to erythromycin.

41
New cards

Metronidazole (Flagyl)

An anaerobic and protozoal agent; contraindicated with alcohol due to disulfiram-like reactions and causes a metallic taste.

42
New cards

Nitrofurantoin (Macrobid)

Drug of choice for uncomplicated cystitis; contraindicated in patients with CrCl <60mL/min< 60\,mL/min.

43
New cards

Meningitis Empiric Treatment (Neonates)

Ampicillin (for Listeria) plus Cefotaxime or Gentamicin.

44
New cards

Meningitis Empiric Treatment (> 50y or Immunocompromised)

Ampicillin (for Listeria) plus Ceftriaxone (or Cefotaxime) plus Vancomycin.

45
New cards

Active Tuberculosis Treatment (RIPE)

Intensive phase for 2 months consisting of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol.

46
New cards

Isoniazid (INH) Side Effects

Boxed warning for hepatitis and known to cause peripheral neuropathy (mitigated with Vitamin B6/pyridoxine).

47
New cards

Infective Endocarditis Dental Prophylaxis

Amoxicillin 2g2\,g PO once (30-60 mins before procedure); if allergic to penicillin, use Azithromycin (500mg500\,mg) or Doxycycline (100mg100\,mg).

48
New cards

Syphilis (Primary/Secondary) Treatment

Penicillin G Benzathine (Bicillin L-A) 2.4million units2.4\,\text{million units} IM x 1.